000 01366 a2200373 4500
005 20250517173118.0
264 0 _c20180806
008 201808s 0 0 eng d
022 _a1879-2472
024 7 _a10.1016/j.thromres.2017.09.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGouin-Thibault, Isabelle
245 0 0 _aEvaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.
_h[electronic resource]
260 _bThrombosis research
_cOct 2017
300 _a126-133 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aAntithrombins
_xadministration & dosage
650 0 4 _aDabigatran
_xadministration & dosage
650 0 4 _aFrance
650 0 4 _aHumans
650 0 4 _aPyrazoles
_xadministration & dosage
650 0 4 _aPyridones
_xadministration & dosage
650 0 4 _aRivaroxaban
_xadministration & dosage
700 1 _aFreyburger, Geneviève
700 1 _ade Maistre, Emmanuel
700 1 _aSusen, Sophie
700 1 _aDelavenne, Xavier
700 1 _aGolmard, Jean-Louis
700 1 _aGruel, Yves
700 1 _aSié, Pierre
773 0 _tThrombosis research
_gvol. 158
_gp. 126-133
856 4 0 _uhttps://doi.org/10.1016/j.thromres.2017.09.001
_zAvailable from publisher's website
999 _c27547728
_d27547728